Vita34 ApS: Financial statements 2019
CVR: 27511759
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Vita34 ApS (CVR 27511759) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,434,727 and a net result of DKK -231,088 compared with DKK -4,010,219 the year before. That is a decrease of 49.6% compared with the year before. Equity in the 2019 report amounted to DKK -8,649,564.
- Gross Profit
- DKK 2,434,727
- Profit/Loss
- DKK -231,088
- Equity
- DKK -8,649,564
- Total Assets
- DKK 22,321,085
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2.4M | -231K | -8.6M | 0 |
| 2018 | - | 4.8M | -4M | -8.4M | 12 |
| 2017 | - | 3.3M | -6.1M | -4.4M | 16 |
| 2016 | - | 3.1M | -5.9M | 1.7M | 17 |
| 2015 | 8.1M | 4.9M | -60K | 7.6M | 8 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Vita34 ApS has published its annual report for 2018. Gross profit came to DKK 4,832,080, and the net result was DKK -4,010,219.
About Vita34 ApS
Vita34 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2004. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named StemCare ApS and BIOBANK DANMARK ApS. The management consists of Marion Bartel and Vivien Weise. The company is owned by FamiCord AG. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 3,842,095 and a net result of DKK 1,034,065 compared with DKK 1,030,138 the year before. Equity in the 2025 report amounted to DKK 5,982,880.